Advertisement

  • Published Date

    May 20, 2020
    Learn More, Click Here.

Ad Text

Do You Have Hearing Loss? CLINICAL STUDY: Our clinic is testing an investigational drug called FX-322 that aims to repair damaged sensory cells needed for hearing. Restoring these cells may result in improved hearing for patients. To participate in this research study with FX-322: You must be a male or female adult, 18 to 65 years. Have an established diagnosis of stable sensorineural hearing loss by standard hearing tests. How does FX-322 Work? FX-322 is being developed by Frequency Therapeutics, Inc. for the treatment of hearing loss. FX-322 is a combination of two different medications, injected through the eardrum allowing FX-322 to enter the inner ear where sensory cells are located. This is a very fast procedure (the actual injection takes seconds, and the entire procedure under 15 minutes). Such injections are very common, are performed in the offices of ear, nose and throat doctors, and are well tolerated by patients. Who is paying for this study? The study is being funded by Frequency Therapeutics, Inc., a company dedicated to developing treatments for the most common form of hearing loss. There will be no cost to your insurance company to be in this study. Frequency Therapeutics, Inc. will pay for the costs of the study drug, study-related tests and procedures and study visits. Contact Information If you want any further information concerning this study, you can contact the Principal study doctor at 804-330-5501 or Studies@RichmondENT.com. Ask Us About FX-322 Today! CENT EN (ENT ENT Do You Have Hearing Loss? CLINICAL STUDY: Our clinic is testing an investigational drug called FX-322 that aims to repair damaged sensory cells needed for hearing. Restoring these cells may result in improved hearing for patients. To participate in this research study with FX-322: You must be a male or female adult, 18 to 65 years. Have an established diagnosis of stable sensorineural hearing loss by standard hearing tests. How does FX-322 Work? FX-322 is being developed by Frequency Therapeutics, Inc. for the treatment of hearing loss. FX-322 is a combination of two different medications, injected through the eardrum allowing FX-322 to enter the inner ear where sensory cells are located. This is a very fast procedure (the actual injection takes seconds, and the entire procedure under 15 minutes). Such injections are very common, are performed in the offices of ear, nose and throat doctors, and are well tolerated by patients. Who is paying for this study? The study is being funded by Frequency Therapeutics, Inc., a company dedicated to developing treatments for the most common form of hearing loss. There will be no cost to your insurance company to be in this study. Frequency Therapeutics, Inc. will pay for the costs of the study drug, study-related tests and procedures and study visits. Contact Information If you want any further information concerning this study, you can contact the Principal study doctor at 804-330-5501 or Studies@RichmondENT.com. Ask Us About FX-322 Today! CENT EN (ENT ENT